US EditionFDA Approves Merck's BRAVECTO QUANTUM Annual Flea And Tick Shot For Dogs
UNITED STATES, JUL 10 – BRAVECTO QUANTUM offers dogs 8 to 12 months of flea and tick protection with a single injection, improving convenience and safety, FDA approved on July 10, 2025.
- On July 10, 2025, Merck Animal Health announced that the FDA approved BRAVECTO QUANTUM, a once-a-year injectable product designed to protect dogs in the U.S. from fleas and ticks.
- This approval builds on earlier authorizations granted in 2023 throughout Australia and New Zealand, as well as the European Union's clearance in 2024, demonstrating ongoing international regulatory advancement.
- BRAVECTO QUANTUM offers 8 to 12 months of protection per injection, must be administered by licensed veterinarians, and is suitable for dogs aged six months and older.
- Merck highlighted the treatment's unprecedented duration as a "new standard in pet care," while the FDA noted isoxazoline drugs like fluralaner have rare neurological risks for some dogs.
- The product will become available nationwide in August 2025, providing a convenient, long-lasting option amid year-round flea and tick threats, though veterinarians will monitor for side effects.
20 Articles
20 Articles
Blockbuster long acting flea and tick treatment for dogs coming after FDA approval
A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the Food and Drug Administration (FDA).The approval of the new injectable treatment, called Bravecto Quantum, was announced by the federal agency on Thursday.It is the "first FDA-approved drug that protects dogs against fleas and ticks for 8 to 12 months," according to the FDA. Bravecto Quantum can be used for treating and pre…
MyCentralOregon.com
FDA approves 12-month flea treatment for dogs, marking veterinary breakthrough
STOCK PHOTO/Getty Images (WASHINGTON) — Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday. The U.S. Food and Drug Administration has given the green light to Bravecto Quantum, the first-ever flea and tick preventative that can protect dogs for up to 12 months with a single injection. The treatment is approved for dogs and puppies 6 months and ol…
At a milestone in veterinary medicine, the U.S. Food and Drug Administration (FDA) approved Bravecto Quantum, an injectable treatment that offers up to 12 months of protection against fleas and ticks in dogs. According to information cited by ABC News, this solution, developed by Intervet Inc. (based in Rahway, New Jersey), represents the first long-term formulation administered by injection. READ ALSO: TRUMP IMPONE ARANCELES 35% TO PRODUCTS OF …
Coverage Details
Bias Distribution
- 60% of the sources are Center
To view factuality data please Upgrade to Premium
